These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26344479)

  • 21. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection.
    Pediatrics; 1999 Apr; 103(4 Pt 1):843-52. PubMed ID: 10103321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of serious bacterial infection in children with fever without a source in the post-Haemophilus influenzae era when antibiotics are reserved for culture-proven bacteremia.
    Bandyopadhyay S; Bergholte J; Blackwell CD; Friedlander JR; Hennes H
    Arch Pediatr Adolesc Med; 2002 May; 156(5):512-7. PubMed ID: 11980559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Febrile infant].
    Hagelberg N; Salmenpohja H; Jalanko H
    Duodecim; 1996; 112(6):511-9. PubMed ID: 10592614
    [No Abstract]   [Full Text] [Related]  

  • 24. National trends in emergency department use of urinalysis, complete blood count, and blood culture for fever without a source among children aged 2 to 24 months in the pneumococcal conjugate vaccine 7 era.
    Simon AE; Lukacs SL; Mendola P
    Pediatr Emerg Care; 2013 May; 29(5):560-7. PubMed ID: 23603643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency department versus office setting and physician/patient kinship effects in the diagnostic and therapeutic choices of febrile children at risk for occult bacteremia.
    Yamamoto LG; Boychuk RB
    Hawaii Med J; 1997 Aug; 56(8):209-14. PubMed ID: 9293153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult bacteremia in the 3-month-old to 3-year-old age group.
    Harper MB; Fleisher GR
    Pediatr Ann; 1993 Aug; 22(8):484, 487-93. PubMed ID: 8414704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era.
    Chancey RJ; Jhaveri R
    Minerva Pediatr; 2009 Oct; 61(5):489-501. PubMed ID: 19794375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection.
    Pulliam PN; Attia MW; Cronan KM
    Pediatrics; 2001 Dec; 108(6):1275-9. PubMed ID: 11731648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fever without apparent source on clinical examination.
    McCarthy P
    Curr Opin Pediatr; 2005 Feb; 17(1):93-110. PubMed ID: 15659971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of children at risk for occult bacteremia.
    Givens TG; Walsh-Kelly C; Glaeser P; Melzer-Lange M; Hennes H; Polhill RB; Hardwick WE; Monroe KW; Nichols MH; Edwards KH
    Pediatr Emerg Care; 1996 Dec; 12(6):460-2. PubMed ID: 8989802
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of the Rochester Criteria to Identify Febrile Infants With Bacteremia and Meningitis.
    Aronson PL; McCulloh RJ; Tieder JS; Nigrovic LE; Leazer RC; Alpern ER; Feldman EA; Balamuth F; Browning WL; Neuman MI;
    Pediatr Emerg Care; 2019 Jan; 35(1):22-27. PubMed ID: 29406479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial Infections.
    Kuppermann N; Dayan PS; Levine DA; Vitale M; Tzimenatos L; Tunik MG; Saunders M; Ruddy RM; Roosevelt G; Rogers AJ; Powell EC; Nigrovic LE; Muenzer J; Linakis JG; Grisanti K; Jaffe DM; Hoyle JD; Greenberg R; Gattu R; Cruz AT; Crain EF; Cohen DM; Brayer A; Borgialli D; Bonsu B; Browne L; Blumberg S; Bennett JE; Atabaki SM; Anders J; Alpern ER; Miller B; Casper TC; Dean JM; Ramilo O; Mahajan P;
    JAMA Pediatr; 2019 Apr; 173(4):342-351. PubMed ID: 30776077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of Accuracy of Biomarkers and Physical Examination to Detect Bacterial Infection in Febrile Infants.
    Díaz MG; García RP; Gamero DB; González-Tomé MI; Romero PC; Ferrer MM; Contreras JR
    Pediatr Emerg Care; 2016 Oct; 32(10):664-668. PubMed ID: 25822238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of bacteremia in infants and children with fever and petechiae.
    Mandl KD; Stack AM; Fleisher GR
    J Pediatr; 1997 Sep; 131(3):398-404. PubMed ID: 9329416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of informed consent principles in the emergency department evaluation of febrile children at risk for occult bacteremia.
    Yamamoto LG
    Hawaii Med J; 1997 Nov; 56(11):313-7, 320-2. PubMed ID: 9420350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old.
    Mahajan P; Grzybowski M; Chen X; Kannikeswaran N; Stanley R; Singal B; Hoyle J; Borgialli D; Duffy E; Kuppermann N
    Acad Emerg Med; 2014 Feb; 21(2):171-9. PubMed ID: 24673673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of bacteremia, urinary tract infections, and unsuspected bacterial meningitis in children with febrile seizures.
    Teach SJ; Geil PA
    Pediatr Emerg Care; 1999 Feb; 15(1):9-12. PubMed ID: 10069303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective multicenter evaluation of adherence to the Dutch guideline for children aged 0-16 years with fever without a source-febrile illness in children (FINCH) study.
    Keuning MW; Klarenbeek NN; Bout HJ; Broer A; Draaijer M; Hol J; Hollander N; Merelle M; Nassar-Sheikh Rashid A; Nusman C; Oostenbroek E; Ridderikhof ML; Roelofs M; van Rossem E; van der Schoor SRD; Schouten SM; Taselaar P; Vasse K; van Wermeskerken AM; van der Zande JMJ; Zuurbier R; Bijlsma MW; Pajkrt D; Plötz FB
    Eur J Pediatr; 2024 Jul; 183(7):2921-2933. PubMed ID: 38619569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.